Sun.Sep 24, 2023

article thumbnail

EMCrit 358 – Dizziness Makes Me Dizzy Still! – GRACE-3 and more with Peter Johns

EMCrit Project

Do you still cringe when a dizzy patient appears on your board? If so, we need to fix that and Peter Johns is here to help! EMCrit Project by Scott Weingart, MD FCCM.

88
article thumbnail

EXCLUSIVE: The 340B Program Reached $54 Billion in 2022—Up 22% vs. 2021

Drug Channels

Drug Channels has just obtained new details on the size of the 340B Drug Pricing Program. I couldn’t wait to share the news, hence this special Sunday post. For 2022, discounted purchases under the 340B program reached a record $53.7 billion —an astonishing $9.8 billion (+22.3%) higher than its 2021 counterpart. The difference between list prices and discounted 340B purchases also grew, to $52.3 billion (+$2.6 billion).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

From Powder to Particles - Inhalation Particle Engineering With Jet Milling

PharmaTech

Jet milling is a well-established particle engineering technique for producing micronized powders with controlled particle size distribution and increased surface area. This makes them suitable for inhalation drug delivery. However, successful implementation of jet milling requires a robust Quality by Design (QbD) approach that ensures the critical quality attributes of the micronized particles are maintained throughout the process development.

article thumbnail

Episode 855: Effect of phenylephrine push prior to continuous infusion norepinephrine in patients with septic shock

Pharmacy Joe

In this episode, I’ll discuss the effect of phenylephrine push prior to continuous infusion norepinephrine in patients with septic shock. Episode 855: Effect of phenylephrine push prior to continuous infusion norepinephrine in patients with septic shock Subscribe on iTunes , Android , or Stitcher Push dose vasopressors as a temporizing measure for profound hypotension in critically ill patients is frequently used in many institutions.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

BIG Change to the Real Life Pharmacology Podcast! Asthma Pharmacology Q&A With Clinical Pharmacist and Expert Beth Zerr, PharmD, BCACP

Med Ed 101

I’m so excited to try something different today and interview one of my great friends! Beth Zerr, PharmD, BCACP was able to share some wisdom on one of the topic areas that she teaches to not only patients but pharmacy students. We cover asthma pharmacology and more specifically, some of the things that she encounters […] The post BIG Change to the Real Life Pharmacology Podcast!

52
article thumbnail

FDA Clears Investigational New Drug Application for Influenza Antiviral

PharmExec

Via Nova Therapeutics’ VNT-101 is an Influenza A nucleoprotein inhibitor.

52

More Trending

article thumbnail

908 Devices Launches Real-Time Monitoring Platform For Multiple Bioprocess Parameters

PharmExec

The device, Maverick, utilizes Raman spectroscopy for bioprocess control.

52
article thumbnail

Psychedelic drug market to reach $7.2 bn in 2029: GlobalData

Express Pharma

The psychedelic drug market is on the brink of extraordinary growth, projected to soar to $7.2 billion by 2029, reflecting a robust 55 per cent compound annual growth rate (CAGR). This ascent is propelled by favorable regulatory developments, including pioneering clinical trial guidelines from the FDA. These guidelines, crafted in response to promising psychedelic clinical results in mental health disorders, position psychedelics as beacons of hope in the field, according to GlobalData.

article thumbnail

CPSC Decision Highlights Some Don’ts of Agency Rulemaking

FDA Law Blog: Biosimilars

By Faraz Siddiqui — Every parent is familiar with the parade of horrors that accompany household items as mundane as window coverings. The cords that dangle from blinds are universally recognized as a grave danger to infants and children. It is also a hot-button issue for the U.S. Consumer Product Safety Commission (CPSC), the federal agency charged with monitoring and enforcing against dangerous consumer products.

59